|
Oral Presentation 3 COPD 1 |
09:00-09:30 |
||
|---|---|---|---|
| Chair | |||
| 15:30-15:40 | OP 3-1 |
Longitudinal Clinical Course of Preserved Ratio Impaired Spirometry Compared to COPD
|
|
| 15:40-15:50 | OP 3-2 |
Neversmoker COPD – Does It Have a Different Clinical Course?
|
|
| 15:50-16:00 | OP 3-3 |
Longitudinal Changes in Forced Expiratory Volume in 1 s in Patients with Eosinophilic Chronic Obstructive Pulmonary Disease
|
|
| 16:00-16:10 | OP 3-4 |
Difference of Clinical Characteristics between Mild and Severe Chronic Bronchitis in Patients with Chronic Obstructive Pulmonary Disease
|
|
| 16:10-16:20 | OP 3-5 |
Clinical Significance of Bronchodilator Response in Chronic Obstructive Pulmonary Disease
|
|
| 16:20-16:30 | OP 3-6 |
Clinical Implication of Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) to Reflect Disease Control in Patients with COPD
|
|
| 16:30-16:40 | OP 3-7 |
Clinical Significance of Various Pathogens in Acute Exacerbations of COPD: Multi-center Study in Korea
|
|
| 16:40-16:50 | OP 3-8 |
Pathogen Distribution in the State of Acute Exacerbation According to GOLD Classification of COPD: A Multicenter Cross-sectional Study
|
|
| 16:50-17:00 | OP 3-9 |
The Utility of Pneumococcal Urinary Antigen Test in Moderate Exacerbation of Chronic Obstructive Pulmonary Disease
|
|
| 17:00-17:10 | OP 3-10 |
Clinical Values of Diaphragmatic Movement in Patients with Chronic Obstructive Pulmonary Disease
|
|